ERNAW Ernexa Therapeutics Inc. - Warrants
$0,08
Fiyat · Ağu 19, 2026
Temel veriler itibarıyla Ağu 6, 2026
52 Haftlık Aralık
$0–$0
28% of range
Analist Derecelendirmesi
—
Fiyat Hedefi
—
P/E (TTM)
—
ROE
-411.6%
Net Kâr Marjı
—
ERNAW Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.08
Piyasa Değeri
—
P/E (TTM)
—
EPS (TTM)
$-2.24
Gelir (TTM)
—
Temettü Verimi
—
ROE
-411.6%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$0 – $0
ERNAW Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
—
2016-12-31
→
2024-12-31
Hisse Başına Kâr
$-2.24
2020-12-31
→
2025-12-31
Serbest Nakit Akışı
$-7M
2016-12-31
→
2025-12-31
Marjlar
—
2024-12-31
→
2024-12-31
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
ERNAW
Akran Ortalaması
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
ERNAW
Akran Ortalaması
ROA
-253.7%
—
ROE
-411.6%
—
ROIC
-386.9%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
ERNAW
Akran Ortalaması
Current Ratio (Cari Oran)
1.0
—
Quick Ratio (Cari Oran)
0.6
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
ERNAW
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
755.9%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
-77.3%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
ERNAW
Akran Ortalaması
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $582.0K | $68.0K | $0 | · | $6M | $20M | $23M | $21M | $22M | $25M | $26M | |
| Cost of Revenue | · | $96.0K | $236.0K | $0 | · | · | · | · | · | · | · | · | |
| Gross Profit | · | $486.0K | $-168.0K | $0 | · | · | · | · | · | · | · | · | |
| R&D Expense | · | · | · | · | · | $2.0K | $26.0K | $72.0K | $139.0K | · | · | · | |
| SG&A Expense | $5M | $13M | $15M | $17M | $15M | $3M | $13M | $14M | $16M | $16M | $18M | $18M | |
| Operating Expenses | $9M | $16M | $21M | $33M | $114M | $7M | $22M | $23M | $23M | $25M | $31M | $31M | |
| Operating Income | $-9M | $-16M | $-21M | $-33M | $-114M | $-7M | $-2M | $203.0K | $-1M | $-2M | $-7M | $-5M | |
| Interest Expense | · | · | $614.0K | $30.0K | · | · | · | · | · | · | · | $223.0K | |
| Other Non-op | $215.0K | $70.0K | $-334.0K | $-1M | $899.0K | $-43.0K | $-258.0K | $-526.0K | $391.0K | $-31.0K | $-319.0K | $-204.0K | |
| Pretax Income | $-14M | $-45M | $-22M | $-25M | $-122M | $-7M | $-2M | $-323.0K | $-1M | $-3M | $-7M | $-5M | |
| Income Tax | $-45.0K | $30.0K | $-3.0K | $45.0K | $64.0K | $0 | $27.0K | $-64.0K | $66.0K | $38.0K | $12.0K | $84.0K | |
| Net Income | $-14M | $-45M | $-22M | $-25M | $-123M | $-7M | $-2M | $-259.0K | $-1M | $-3M | $-7M | $-5M | |
| EPS (Basic) | $-2.24 | $-48.96 | $-4.08 | $-8.06 | $-56.61 | $-0.41 | · | · | · | · | · | · | |
| EPS (Diluted) | $-2.24 | $-48.96 | $-4.08 | $-8.06 | $-56.61 | $-0.41 | · | · | · | · | · | · | |
| Shares (Basic) | 6,307,000 | 910,000 | 5,314,000 | 3,051,000 | 2,165,000 | 17,588,000 | · | · | · | · | · | · | |
| Shares (Diluted) | 6,307,000 | 910,000 | 5,314,000 | 3,051,000 | 2,165,000 | 17,588,000 | · | · | · | · | · | · | |
| EBITDA | $-9M | $-16M | · | $-33M | $-114M | $-6M | · | $3M | $915.0K | $609.0K | $-4M | $-2M |
Bilanço 27
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $2M | $8M | $11M | $17M | $2M | $3M | $3M | $3M | $6M | $3M | $7M | |
| Receivables | · | · | · | · | $684.0K | $0 | $1M | $1M | $714.0K | $928.0K | $919.0K | $2M | |
| Prepaid Expense | $404.0K | $186.0K | $2M | $1M | $1M | $102.0K | $526.0K | $517.0K | $680.0K | $1M | $978.0K | $742.0K | |
| Current Assets | $3M | $2M | $10M | $14M | $19M | $2M | $6M | $7M | $10M | $11M | $9M | $15M | |
| PP&E (Net) | $94.0K | $85.0K | $493.0K | $236.0K | $670.0K | $594.0K | $3M | $5M | $4M | $3M | $4M | $3M | |
| PP&E (Gross) | $291.0K | $257.0K | $607.0K | $268.0K | $877.0K | $714.0K | $12M | $15M | $14M | $14M | $16M | $23M | |
| Accum. Depreciation | $197.0K | $172.0K | $114.0K | $32.0K | $207.0K | $120.0K | $9M | $11M | $10M | $11M | $12M | $19M | |
| Goodwill | $2M | $2M | $2M | $2M | $2M | $2M | $696.0K | $667.0K | $1M | $937.0K | $909.0K | $1M | |
| Intangibles | · | · | · | · | · | · | $696.0K | $667.0K | $1M | $29.0K | $79.0K | $129.0K | |
| Other Non-current Assets | $110.0K | $118.0K | $120.0K | $1M | $488.0K | $50.0K | $97.0K | $103.0K | $16.0K | $92.0K | $124.0K | $57.0K | |
| Total Assets | $6M | $5M | $49M | $22M | $32M | $13M | $14M | $15M | $17M | $17M | $16M | $22M | |
| Accounts Payable | $1M | $2M | $1M | $2M | $2M | $1M | $835.0K | $271.0K | $390.0K | $247.0K | $211.0K | $617.0K | |
| Accrued Liabilities | $898.0K | $1M | $2M | $4M | $1M | $1M | $490.0K | $444.0K | $418.0K | $697.0K | $670.0K | $969.0K | |
| Current Liabilities | $3M | $3M | $7M | $8M | $4M | $3M | $6M | $4M | $11M | $7M | $5M | $7M | |
| Capital Leases | $277.0K | $477.0K | $33M | $887.0K | $2M | $2M | $3M | $41.0K | $164.0K | $259.0K | $138.0K | $30.0K | |
| Other Non-current Liabilities | $43.0K | $111.0K | $84.0K | $94.0K | $48.0K | $23.0K | $26.0K | · | $52.0K | $12.0K | $0 | $7.0K | |
| Total Liabilities | $3M | $4M | $47M | $10M | $6M | $5M | $9M | $8M | $11M | $13M | $13M | $11M | |
| Long-term Debt | · | · | · | · | · | $2M | · | $4M | $5M | $8M | $7M | $5M | |
| Total Debt | · | · | · | · | · | $2M | · | $1M | $5M | $3M | $1M | $2M | |
| Common Stock | $2.0K | $17.0K | $27.0K | $26.0K | $13.0K | $0 | $14.0K | $14.0K | $13.0K | $11.0K | $9.0K | $462.0K | |
| Paid-in Capital | $248M | $233M | $189M | $177M | $166M | $0 | $137M | $137M | $135M | $132M | $129M | $128M | |
| Retained Earnings | $-246M | $-232M | $-187M | $-165M | $-141M | $-18M | $-131M | $-129M | $-129M | $-128M | $-125M | $-118M | |
| Treasury Stock | · | · | · | · | · | $456.0K | $456.0K | $456.0K | $456.0K | $456.0K | $456.0K | $456.0K | |
| AOCI | · | · | · | · | · | $245.0K | $268.0K | $200.0K | $345.0K | $223.0K | $172.0K | $479.0K | |
| Stockholders' Equity | $2M | $2M | $2M | $12M | $26M | $8M | $10M | $7M | $6M | $4M | $4M | $11M | |
| Liabilities + Equity | $6M | $5M | $49M | $22M | $32M | $13M | $14M | $15M | $17M | $17M | $16M | $22M | |
| Shares Outstanding | 314,000 | 3,426,000 | 5,410,000 | 5,127,000 | 2,601,000 | 0 | 2,901,000 | 2,875,000 | 2,521,000 | 2,261,000 | 1,849,000 | 92,370,000 |
Nakit Akışı 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $65.0K | $139.0K | $84.0K | $161.0K | $117.0K | $98.0K | $3M | $3M | $2M | $3M | $3M | $3M | |
| Stock-based Comp | $1M | $2M | $1M | $3M | $5M | $91.0K | $206.0K | $443.0K | $457.0K | $419.0K | $456.0K | $282.0K | |
| Deferred Tax | $-48.0K | $27.0K | $-4.0K | $-9M | $-7M | $-322.0K | $-4.0K | $69.0K | $-34.0K | $-12.0K | $-10.0K | $-23.0K | |
| Amort. of Intangibles | · | · | · | · | · | · | · | $29.0K | · | $50.0K | $50.0K | $181.0K | |
| Other Non-cash | $6M | $27M | · | $9M | $101M | · | · | $-2M | $-1M | $-348.0K | $-504.0K | $-4M | |
| Operating Cash Flow | $-7M | $-16M | $-20M | $-21M | $-23M | $-8M | $3M | $1M | $549.0K | $23.0K | $-4M | $-6M | |
| CapEx | $37.0K | $369.0K | $19.0K | $297.0K | $154.0K | $39.0K | $128.0K | $648.0K | $728.0K | $427.0K | $991.0K | $835.0K | |
| Investing Cash Flow | $-37.0K | $-365.0K | $-19.0K | $-47.0K | $-23M | $-39.0K | $-1M | $-2M | $-1M | $-840.0K | $-2M | · | |
| Debt Issued | · | · | · | · | · | $3M | · | $4M | $50.0K | $3M | $7M | $6M | |
| Net Debt Issued | · | · | · | · | · | $375.0K | · | $-1M | $-3M | $673.0K | $2M | · | |
| Stock Issued | $5M | $1M | · | $20M | $0 | $0 | · | $1M | $2M | $3M | · | $6M | |
| Net Stock Activity | $5M | $1M | · | $20M | $52M | · | · | $1M | $2M | $3M | · | $6M | |
| Financing Cash Flow | $7M | $6M | $17M | $20M | $62M | $5M | $-1M | $-303.0K | $-1M | $3M | $2M | · | |
| Net Change in Cash | · | · | · | · | · | $-3M | $623.0K | $-592.0K | $-2M | $2M | $-4M | $2M | |
| Taxes Paid | $3.0K | $3.0K | $4.0K | $15.0K | $1.0K | $0 | $26.0K | $17.0K | $36.0K | $47.0K | $69.0K | $35.0K | |
| Free Cash Flow | $-7M | $-16M | · | $-21M | $-24M | · | · | $717.0K | $-179.0K | $-404.0K | $-5M | $-7M | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $-7M |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 83.5% | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | · | -2693.1% | · | · | · | -108.8% | · | 0.87% | -6.6% | -10.2% | -28.1% | -18.2% | |
| Net Margin | · | -7652.8% | · | · | · | -76.1% | · | -1.1% | -5.1% | -13.1% | -29.5% | -19.3% | |
| Pretax Margin | · | -7647.6% | · | · | · | -76.2% | · | -1.4% | -4.8% | -12.9% | -29.4% | -19.0% | |
| EBITDA Margin | · | -2669.2% | · | · | · | -108.8% | · | 12.7% | 4.3% | 2.7% | -15.5% | -7.7% | |
| ROA | -253.7% | -163.7% | · | -91.4% | · | -49.4% | · | -1.7% | -6.5% | -17.7% | -37.4% | -26.7% | |
| ROE | -411.6% | 203.9% | · | -235.0% | · | -83.2% | · | -3.8% | -22.4% | -73.9% | -97.8% | -50.0% | |
| ROIC | -386.9% | -922.1% | · | -274.9% | · | -218.5% | · | 2.1% | -14.1% | -32.7% | -140.4% | -36.8% |
Likidite ve Solventlik 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.0 | 0.8 | · | 1.8 | · | 0.7 | · | 1.7 | 0.9 | 1.6 | 1.8 | 2.1 | |
| Quick Ratio | 0.6 | 0.6 | · | 1.5 | · | 0.4 | · | 0.9 | 0.4 | 1.0 | 0.8 | 1.3 | |
| Debt / Equity | · | · | · | · | · | 2.4 | · | 0.1 | 0.9 | 0.7 | 0.3 | 0.2 | |
| LT Debt / Equity | · | · | · | · | · | 0.6 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -21.3 |
Verimlilik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | · | · | 0.6 | · | 1.5 | 1.3 | 1.3 | 1.3 | 1.4 | |
| Receivables Turnover | · | · | · | · | · | 8.8 | · | 25.1 | 25.9 | 24.2 | 15.8 | 18.4 |
Büyüme Oranları 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | 755.9% | · | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | · | -77.3% | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $632.0K | $582.0K | $68.0K | $0 | $9M | $6M | $20M | $23M | $21M | $22M | $25M | $26M | |
| Net Income TTM | $-14M | $-45M | $-22M | $-25M | $-123M | $-7M | $-2M | $-259.0K | $-1M | $-3M | $-7M | $-5M |
Gelir Tablosu 16
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | $1.0K | $487.0K | $47.0K | $47.0K | $17.0K | $51.0K | · | $0 | $0 | $0 | · | |
| Cost of Revenue | $0 | · | · | $0 | · | $0 | $-60.0K | $95.0K | $61.0K | $66.0K | $120.0K | · | $50.0K | $0 | $0 | · | |
| Gross Profit | · | · | · | · | · | $1.0K | $547.0K | $-48.0K | $-14.0K | $-49.0K | $-69.0K | · | $-50.0K | $0 | $0 | · | |
| R&D Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | |
| SG&A Expense | $1M | $1M | $958.0K | $1M | $1M | $2M | $3M | $4M | $4M | $4M | $4M | $3M | $4M | $3M | $3M | $6M | |
| Operating Expenses | $4M | $2M | $2M | $3M | $3M | $3M | $3M | $5M | $6M | $6M | $5M | $5M | $5M | $5M | $8M | $14M | |
| Operating Income | $-4M | $-2M | $-2M | $-3M | $-3M | $-3M | $-2M | $-5M | $-6M | $-6M | $-6M | $-5M | $-5M | $-5M | $-8M | $-14M | |
| Other Non-op | $-1.0K | $479.0K | $-6.0K | $-123.0K | $-135.0K | · | · | · | · | $42.0K | $-1.0K | $-280.0K | $-95.0K | $-11M | $993.0K | $10M | |
| Pretax Income | $-4M | $-2M | $-1M | $-3M | $-8M | $-6M | $-27M | $-6M | $-7M | $-6M | $-6M | $-5M | $-5M | $-4M | $-7M | $-3M | |
| Income Tax | · | $-62.0K | $6.0K | $3.0K | $8.0K | $11.0K | $12.0K | $3.0K | $4.0K | $-4.0K | $-8.0K | $4.0K | $5.0K | $40.0K | $5.0K | $0 | |
| Net Income | $-4M | $-2M | $-1M | $-3M | $-8M | $-6M | $-27M | $-6M | $-7M | $-6M | $-6M | $-5M | $-5M | $-4M | $-7M | $-3M | |
| EPS (Basic) | $-3.40 | $-1.33 | $-0.15 | $-15.19 | $-0.15 | $41.31 | $-73.70 | $-15.34 | $-1.23 | $-1.14 | $-1.03 | $-0.85 | $-1.06 | $-0.91 | $-2.49 | $-1.16 | |
| EPS (Diluted) | $-3.40 | $-1.33 | $-0.15 | $-15.19 | $-0.15 | $41.31 | $-73.70 | $-15.34 | $-1.23 | $-1.14 | $-1.03 | $-0.85 | $-1.06 | $-0.91 | $-2.49 | $-1.16 | |
| Shares (Basic) | 1,183,000 | -60,459,000 | 8,226,000 | 207,000 | 53,361,000 | -5,222,000 | 361,000 | 361,000 | 5,410,000 | -10,526,000 | 5,410,000 | 5,303,000 | 5,127,000 | -5,511,000 | 2,941,000 | 2,940,000 | |
| Shares (Diluted) | 1,183,000 | -60,459,000 | 8,226,000 | 207,000 | 53,361,000 | -5,222,000 | 361,000 | 361,000 | 5,410,000 | -10,526,000 | 5,410,000 | 5,303,000 | 5,127,000 | -5,511,000 | 2,941,000 | 2,940,000 | |
| EBITDA | $-4M | · | $-2M | $-3M | $-3M | · | $-2M | $-5M | $-6M | · | $-6M | $-5M | $-5M | · | $-8M | $-14M |
Bilanço 23
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $2M | $3M | $4M | $2M | $2M | $4M | $3M | $5M | $8M | $5M | $2M | $5M | $11M | $13M | $19M | |
| Prepaid Expense | $783.0K | $404.0K | $179.0K | $323.0K | $137.0K | $186.0K | $279.0K | $769.0K | $697.0K | $2M | $704.0K | $1M | $471.0K | $1M | $2M | $2M | |
| Current Assets | $6M | $3M | $3M | $5M | $2M | $2M | $5M | $4M | $6M | $10M | $7M | $4M | $7M | $14M | $16M | $22M | |
| PP&E (Net) | $82.0K | $94.0K | $92.0K | $50.0K | $67.0K | $85.0K | $105.0K | $654.0K | $710.0K | $493.0K | $173.0K | $193.0K | $215.0K | $236.0K | $231.0K | $424.0K | |
| PP&E (Gross) | · | $291.0K | · | · | · | $257.0K | · | · | · | $607.0K | · | · | · | $268.0K | · | · | |
| Accum. Depreciation | · | $197.0K | · | · | · | $172.0K | · | · | · | $114.0K | · | · | · | $32.0K | · | · | |
| Goodwill | · | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $25.0K | $110.0K | $116.0K | $117.0K | $118.0K | $118.0K | $120.0K | $120.0K | $120.0K | $120.0K | $4M | $1M | $1M | $1M | $819.0K | · | |
| Total Assets | $6M | $6M | $6M | $8M | $5M | $5M | $8M | $46M | $50M | $49M | $52M | $47M | $15M | $22M | $21M | $27M | |
| Accounts Payable | $1M | $1M | $958.0K | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $3M | $1M | $2M | $1M | $1M | |
| Accrued Liabilities | $1M | $898.0K | $859.0K | $938.0K | $1M | $1M | $1M | $2M | $2M | $2M | $5M | $2M | $2M | $4M | $3M | $4M | |
| Short-term Debt | · | · | · | · | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $3M | $3M | $2M | $3M | $10M | $3M | $10M | $10M | $8M | $7M | $10M | $7M | $5M | $8M | $7M | $7M | |
| Capital Leases | $182.0K | $277.0K | $346.0K | $376.0K | $419.0K | $477.0K | $534.0K | $36M | $37M | $33M | $35M | $35M | $841.0K | $887.0K | $2M | $2M | |
| Other Non-current Liabilities | $1.0K | $43.0K | $112.0K | $113.0K | $111.0K | $111.0K | $84.0K | $84.0K | $84.0K | $84.0K | · | · | $87.0K | · | $2M | $48.0K | |
| Total Liabilities | $3M | $3M | $3M | $3M | $11M | $4M | $53M | $55M | $53M | $47M | $49M | $43M | $8M | $10M | $12M | $12M | |
| Total Debt | · | · | · | · | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $6.0K | $39.0K | $39.0K | $37.0K | $262.0K | $17.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $26.0K | $26.0K | $15.0K | $287.0K | |
| Paid-in Capital | $258M | $248M | $248M | $247M | $234M | $233M | $180M | $191M | $190M | $189M | $184M | $179M | $178M | $177M | $170M | $168M | |
| Retained Earnings | $-255M | $-246M | $-244M | $-243M | $-240M | $-232M | $-226M | $-199M | $-194M | $-187M | $-181M | $-175M | $-171M | $-165M | $-161M | $-153M | |
| Stockholders' Equity | $3M | $2M | $4M | $4M | $-6M | $2M | $-45M | $-9M | $-3M | $2M | $4M | $4M | $7M | $12M | $9M | $15M | |
| Liabilities + Equity | $6M | $6M | $6M | $8M | $5M | $5M | $8M | $46M | $50M | $49M | $52M | $47M | $15M | $22M | $21M | $27M | |
| Shares Outstanding | 1,170,000 | 7,854,000 | 7,849,000 | 7,483,000 | 52,250,000 | 3,426,000 | 5,411,000 | 5,411,000 | 5,410,000 | 5,410,000 | 5,410,000 | 5,410,000 | 5,127,000 | 5,127,000 | 2,942,000 | 57,469,000 |
Nakit Akışı 11
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9.0K | $13.0K | $17.0K | $17.0K | $18.0K | $19.0K | $37.0K | $44.0K | $39.0K | $22.0K | $20.0K | $21.0K | $21.0K | $17.0K | $40.0K | $68.0K | |
| Stock-based Comp | $320.0K | $333.0K | $293.0K | $368.0K | $502.0K | $410.0K | $405.0K | $423.0K | $282.0K | $165.0K | $174.0K | $214.0K | $689.0K | $397.0K | $476.0K | $879.0K | |
| Other Non-cash | · | · | · | · | $6M | · | · | · | $3M | · | · | · | $-1M | · | · | · | |
| Operating Cash Flow | $-4M | $-1M | $-1M | $-3M | $-2M | $-4M | $-6M | $-2M | $-4M | $-5M | $-6M | $-4M | $-6M | $-5M | $-6M | $-4M | |
| CapEx | $3.0K | $15.0K | · | · | · | $0 | $19.0K | $249.0K | $101.0K | $19.0K | $0 | $0 | $0 | $21.0K | $43.0K | $187.0K | |
| Investing Cash Flow | $-3.0K | $-15.0K | · | · | · | $0 | $-19.0K | $-249.0K | $-97.0K | $-19.0K | $0 | $0 | $0 | $129.0K | $-43.0K | $-87.0K | |
| Stock Issued | · | $0 | $0 | · | · | · | · | · | · | · | $0 | $0 | $0 | $8M | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Financing Cash Flow | $6.0K | $0 | $26.0K | $5M | $2M | $1M | $4M | $-22.0K | $1M | $8M | $9M | $312.0K | $0 | $8M | $6.0K | $-13.0K | |
| Taxes Paid | · | $0 | $0 | · | · | $1.0K | $0 | $2.0K | · | $0 | $0 | $4.0K | $0 | $7.0K | $0 | $8.0K | |
| Free Cash Flow | · | · | · | · | · | · | · | · | $-4M | · | · | · | $-6M | · | · | · |
Kârlılık 8
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | 112.3% | -102.1% | -29.8% | · | -135.3% | · | · | · | · | · | |
| Operating Margin | · | · | · | · | · | · | -463.9% | -10491.5% | -12312.8% | · | -10794.1% | · | · | · | · | · | |
| Net Margin | · | · | · | · | · | · | -5462.8% | -11763.8% | -14142.5% | · | -10962.8% | · | · | · | · | · | |
| Pretax Margin | · | · | · | · | · | · | -5460.4% | -11757.5% | -14134.0% | · | -10978.4% | · | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | · | -463.9% | -10491.5% | -12229.8% | · | -10794.1% | · | · | · | · | · | |
| ROA | -57.7% | · | -17.8% | -11.6% | -30.0% | · | -88.7% | -11.8% | -20.5% | · | -15.3% | -12.2% | -21.5% | · | -24.3% | -7.4% | |
| ROE | -104.9% | · | 5.9% | 153.8% | 175.2% | · | 127.2% | 237.3% | -335.0% | · | -90.4% | -48.4% | -43.9% | · | -67.0% | -13.6% | |
| ROIC | · | · | -56.1% | -56.3% | 73.9% | · | 5.0% | 57.9% | 169.7% | · | -154.3% | -117.8% | -72.1% | · | -94.3% | · |
Likidite ve Solventlik 3
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | · | 1.6 | 1.8 | 0.2 | · | 0.5 | 0.4 | 0.8 | · | 0.7 | 0.5 | 1.2 | · | 2.1 | 3.1 | |
| Quick Ratio | 1.7 | · | 1.4 | 1.6 | 0.2 | · | 0.4 | 0.3 | 0.7 | · | 0.5 | 0.3 | 1.0 | · | 1.8 | 2.7 | |
| Debt / Equity | · | · | · | · | -0.4 | · | · | · | · | · | · | · | · | · | · | · |
Verimlilik 1
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · | · | · | · |
Değerleme (TTM) 8
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $632.0K | · | $632.0K | $632.0K | $632.0K | · | $632.0K | · | · | · | · | · | · | · | · | $9M | |
| Net Income TTM | $-14M | · | $-39M | $-43M | $-47M | · | $-44M | $-22M | $-22M | · | $-23M | $-21M | $-26M | · | $-106M | $-109M | |
| Market Cap | $83.4K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/S | 0.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -36030.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | — | $582.0K | $68.0K | $0 | — |
| Brüt Kâr Marjı % | — | 83.5% | — | — | — |
| Faaliyet Kâr Marjı % | — | -2693.1% | — | — | — |
| Net Gelir | $-14M | $-45M | $-22M | $-25M | $-123M |
| Seyreltilmiş Hisse Başı Kâr | $-2.24 | $-48.96 | $-4.08 | $-8.06 | $-56.61 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 1.0 | 0.8 | — | 1.8 | — |
| Cari Oran | 0.6 | 0.6 | — | 1.5 | — |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-7M | $-16M | — | $-21M | $-24M |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 6 dosya · $202K toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 1 | 0 | 1 | 2 | — |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır. Önceki çeyreğe göre değişim gösterilmiyor: başvuru sahibi kapsamı, güvenilir bir karşılaştırma için bu iki çeyrek arasında çok fazla farklılık göstermektedir.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Bleichroeder LP | $142.600 | 2.000.000 | 70,50% | Hisse senetleri |
| HEIGHTS CAPITAL MANAGEMENT, INC | $28.520 | 400.000 | 14,10% | Hisse senetleri |
| ARMISTICE CAPITAL, LLC | $11.408 | 160.000 | 5,64% | Hisse senetleri |
| Clear Street Group Inc. | $10.659 | 149.499 | 5,27% | Hisse senetleri |
| Warberg Asset Management LLC | $4.950 | 69.430 | 2,45% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.128 | 57.890 | 2,04% | Hisse senetleri |
Aktivistler ve %5+ sahipler 7 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Charles Cherington | 22 Aralık 2023 | — | İlk başvuru | — | SEC |
| Ault Global Holdings, Inc. ×2 başvurular | 22 Şubat 2021 | — | İlk başvuru | — | SEC |
| Matador Capital Partners, L.P., BFK Investments LLC, Jeffrey A. Berg ×3 başvurular | 15 Haziran 2020 | — | İlk başvuru | — | SEC |
| North Star Investment Management Corporation ×2 başvurular | 08 Ocak 2020 | — | İlk başvuru | Pasif yatırım | SEC |
| Ram Krishnan | 06 Şubat 2018 | — | İlk başvuru | Pasif yatırım | SEC |
| BFK Investments LLC, Jeffrey A. Berg, Matador Capital Partners, L.P. | 14 Ocak 2011 | — | İlk başvuru | Pasif yatırım | SEC |
| Trinad Capital Master Fund, Ltd., Trinad Management, LLC, Trinad Capital LP, Trinad Advisors II, LLC, Robert S. Ellin, Jay A. Wolf | 24 Temmuz 2007 | — | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.